Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial

Annals of Intensive Care

Table 1 Characteristics of the patients at baseline

Characteristics	Patients (n = 459)
Sex (men/women) n (%)	310/149 (67.5 / 32.5)
Age (year) (± SD)	65.6 (± 13.7)
Weight (± SD)	85.5 (± 22.2)
Chronic renal failure^a n (%)	43 (9)
Congestive heart failure n (%)	41 (9)
Ischemic heart disease n (%)	43 (9)
Hypertension n (%)	235 (51)
Diabetes mellitus n (%)	121 (26)
Invasive mechanical ventilation n (%)	394 (86)
ARDS^b n (%)	156/456 (34)
SAPS III^c (± SD)	73.4 (± 14.0)
SOFA^d (± SD)	11.2 (± 3.0)
Central venous catheter n (%)	411 (90)

All data at enrollment. Plus–minus values are means ± SD (standard deviation)
^aChronic renal failure defined as eGFR < 60 ml/mn
^bARDS: Berlin definition
^cThe Simplified Acute Physiology Score (SAPS) III ranges from 0 to 146, with higher scores indicating more severe disease and a higher risk of death
^dThe Sepsis‐related Organ Failure Assessment (SOFA) score ranges from 0 to 24, with higher scores indicating more severe organ failure